MMSI vs. HAE, ICUI, GKOS, AXNX, IRTC, PRCT, TNDM, NARI, GMED, and IART Should you be buying Merit Medical Systems stock or one of its competitors? The main competitors of Merit Medical Systems include Haemonetics (HAE), ICU Medical (ICUI), Glaukos (GKOS), Axonics (AXNX), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Globus Medical (GMED), and Integra LifeSciences (IART). These companies are all part of the "surgical & medical instruments" industry.
Merit Medical Systems (NASDAQ:MMSI ) and Haemonetics (NYSE:HAE ) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, community ranking, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.
Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
Merit Medical Systems presently has a consensus target price of $92.78, indicating a potential upside of 13.30%. Haemonetics has a consensus target price of $108.67, indicating a potential upside of 13.51%. Given Haemonetics' higher probable upside, analysts clearly believe Haemonetics is more favorable than Merit Medical Systems.
Haemonetics has a net margin of 8.98% compared to Merit Medical Systems' net margin of 7.94%. Haemonetics' return on equity of 22.25% beat Merit Medical Systems' return on equity.
99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 1.8% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Haemonetics had 10 more articles in the media than Merit Medical Systems. MarketBeat recorded 19 mentions for Haemonetics and 9 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.01 beat Haemonetics' score of 0.51 indicating that Merit Medical Systems is being referred to more favorably in the media.
Merit Medical Systems received 29 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 68.90% of users gave Merit Medical Systems an outperform vote while only 60.89% of users gave Haemonetics an outperform vote.
Merit Medical Systems has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500.
Summary Merit Medical Systems and Haemonetics tied by winning 9 of the 18 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Merit Medical Systems Competitors List
Related Companies and Tools
